PharmiWeb.com - Global Pharma News & Resources
11-Jul-2019

Medical Device Testing Services Market Size to Cross USD 14.2 Billion by 2026

The Global Medical Device Testing Services Market Size projected to register USD 14.2 billion by 2026, registering at a CAGR growth of 12.2% over the forecast period 2018 to 2026. Growing expenditure in preclinical phase of medical gadgets paired with rising trend of outsourcing the services is anticipated to boost the market development.

Growing need for in-vitro tests is also anticipated to boost the industry as many CROs are emerging novel in-vitro approaches to replace the traditional approaches that require animal testing. Important progression in the growth and standardization of such novel test approaches, predominantly for cytotoxicity, sensitization, and irritation, is also expected to drive the market growth. There has been an important increase in preclinical expenditure for both pharmaceutical and medical gadgets.

Growing need for in-vitro tests is also anticipated to boost the industry, as a lot of CROs are emerging novel methods to replace the traditional in-vivo tests that require animal testing. Development in the growth and standardization of novel in vitro test approaches; particularly for sensitization, cytotoxicity, and irritation that are the basic test required for all the medical device is also expected to support industry development.

Also, increasing numeral of businesses in this industry is contributing to the industry growth. Structurally, global medical device industry is divided amongst few major players and a huge numeral of (SMEs) Small- and Medium-sized Enterprises. Therefore, rising need from SMEs that lack in-house capabilities, will backing the industry.

Rise of drug device combination, personalized medication, artificial intelligence (AI), wearablersquo;s and focus on real-time patient monitoring resulted in complex medical devices ecosystem. To match these factors, gadgets now have to undergo shear testing in augmented conditions to obtain marketing approval. Conducting these tests in-house needs a lot of time, cost, and labour; this is anticipated to increase the need for outsourcing of these services thereby increasing the market development.

Download Free Report Sample Pages, Click Here at https://www.acumenresearchandconsulting.com/request-sample/965

The global medical device testing service market is segmented into service, phrase and region. On the basis of service the global medical device testing service market is segmented biocompatibility tests, chemistry test, microbiology amp; sterility testing, and package validation. Microbiology amp; Sterility Testing is further bifurcated into bio-burden determination, pyrogen and endotoxin testing, sterility test and validation, anti-microbial activity testing, and other services. On the basis of phrase the global medical device testing service market is segmented into preclinical and clinical. Preclinical sub segment is further bifurcated into antimicrobial wound dressings, medical coatings and others. On the basis of region the global medical device testing service market is segmented into Latin America, Europe, Asia Pacific, North America, and Middle East amp; Africa.

Asia Pacific captures the largest market share in the medical device testing services market due to augmented outsourcing in nations, for instance, as India and China. Contract Research Organizations (CROs) are spending heavily in emerging nations of APAC due to lower cost and easy accessibility of trained labour. North America captures the second-largest share in 2018 and is anticipated to observer important development during the forecast timeframe.

This development can be credited to the fact that it is one of the top industrial hubs of complex, high-end, and reliable medical gadgets. Many CROs have a developed business in the region that delivers complete range of testing services for businesses. The Europe region is led by nations (Germany Spain, U.K., France, and Italy) EU5. Increasing demand for cost cutting and growing difficulty in product designing are anticipated to be the major industry drivers.

The key players catering to the global Medical Device Testing Services market are Medical Device Testing Services, Toxikon, Inc., American Preclinical Services LLC, SGS SA, Charles River Laboratories International, Inc., Eurofins Scientific, LLC, Sterigenics International LLC, Intertek Group PLC, North American Science Associates, Inc., WuXiAppTec Group, and Pace Analytical Services, LLC.

This trend is anticipated to contribute to the industry development over the next few years. Stringent regulatory standards relating to operator safety have also drive the trend of outsourcing medical device testing services. Growing need for quality products is anticipated to further push the need by medical device businesses, increasing the industry development. There has been an important consolidation in the CRO space in coming years.

Such as, Sterigenics International LLC acquired the European division of Toxikon Corp.; Toxikon Europe N.V., in October 2017. The objective of the partnershipto strengthen its preclinical service portfolio for pharmaceutical and medical device businesses.

View Full Report at https://www.acumenresearchandconsulting.com/medical-device-testing-services-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Medical Device Testing Services
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Medical Device Testing Services Market By Service
1.2.2.1. Global Medical Device Testing Services Market Revenue and Growth Rate Comparison By Service (2015-2026)
1.2.2.2. Global Medical Device Testing Services Market Revenue Share By Service in 2017
1.2.2.3. Biocompatibility Tests
1.2.2.4. Chemistry Test
1.2.2.5. Microbiology amp; Sterility Testing
1.2.2.6. Package Validation
1.2.2.7. Others
1.2.3. Medical Device Testing Services Market By Phase
1.2.3.1. Global Medical Device Testing Services Market Revenue and Growth Rate Comparison By Phase (2015-2026)
1.2.3.2. Global Medical Device Testing Services Market Revenue Share By Phase in 2017
1.2.3.3. Preclinical
1.2.3.4. Clinical
1.2.4. Medical Device Testing Services Market by Geography
1.2.4.1. Global Medical Device Testing Services Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Medical Device Testing Services Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Medical Device Testing Services Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Medical Device Testing Services Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Medical Device Testing Services Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Medical Device Testing Services Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Medical Device Testing Services Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Medical Device Testing Services Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Medical Device Testing Services Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Medical Device Testing Services Major Manufacturers in 2017

CHAPTER 4. MEDICAL DEVICE TESTING SERVICES MARKET BY SERVICE

4.1. Global Medical Device Testing Services Revenue By Service
4.2. Biocompatibility Tests
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Chemistry Test
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Microbiology amp; Sterility Testing
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Package Validation
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. MEDICAL DEVICE TESTING SERVICES MARKET BY PHASE

5.1. Global Medical Device Testing Services Revenue By Phase
5.2. Preclinical
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Clinical
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA MEDICAL DEVICE TESTING SERVICES MARKET BY COUNTRY

6.1. North America Medical Device Testing Services Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Medical Device Testing Services Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Medical Device Testing Services Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE MEDICAL DEVICE TESTING SERVICES MARKET BY COUNTRY

7.1. Europe Medical Device Testing Services Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Medical Device Testing Services Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC MEDICAL DEVICE TESTING SERVICES MARKET BY COUNTRY

8.1. Asia-Pacific Medical Device Testing Services Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Medical Device Testing Services Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA MEDICAL DEVICE TESTING SERVICES MARKET BY COUNTRY

9.1. Latin America Medical Device Testing Services Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Medical Device Testing Services Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST MEDICAL DEVICE TESTING SERVICES MARKET BY COUNTRY

10.1. Middle East Medical Device Testing Services Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Medical Device Testing Services Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA MEDICAL DEVICE TESTING SERVICES MARKET BY COUNTRY

11.1. Africa Medical Device Testing Services Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Medical Device Testing Services Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Phase, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Medical Device Testing Services
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Toxikon, Inc.
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. American Preclinical Services LLC
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. SGS SA
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Charles River Laboratories International, Inc.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Eurofins Scientific
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Sterigenics International LLC
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Intertek Group PLC
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. North American Science Associates, Inc.
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. WuXiAppTec Group
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Pace Analytical Services, LLC
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Others
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

INQUIRY BEFORE BUYING: https://www.acumenresearchandconsulting.com/inquiry-before-buying/965

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/965

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 11-Jul-2019